Low dose aspirin in pregnancy who needs it when to start and how it helps prevent preeclampsia

Low-Dose Aspirin in Pregnancy: Who Needs It, When to Start, and How It Helps Prevent Preeclampsia

Low-dose aspirin is recommended in pregnancy for people at increased risk of preeclampsia, and major guidelines specify exactly who should take it, when to start, what dose to use, and its safety profile. The current U.S. standard is 81 mg daily beginning between 12 and 28 weeks (ideally before 16 weeks) and continuing until delivery for those who meet risk-based criteria.

Preeclampsia affects about 1 in 25 pregnancies in the United States and can cause serious complications for both parent and baby if not prevented or detected early. This guide focuses specifically on aspirin prophylaxis—qualifying risk factors, timing and dosing, expected benefits, safety and side effects, medication interactions, and how to integrate a plan with your OB-GYN or midwife.

Key Takeaways

  • Low-dose aspirin (81 mg daily) is recommended for pregnant people at increased risk of preeclampsia, started between 12 and 28 weeks (ideally before 16 weeks) and continued until delivery.
  • High-risk factors include prior preeclampsia, multifetal gestation, chronic hypertension, pregestational diabetes, kidney disease, and autoimmune disease; more than one moderate risk factor also qualifies.
  • Aspirin reduces the risk of preeclampsia by about 15%, preterm birth by about 20%, and fetal growth restriction by about 18% in eligible patients.
  • Safety data show no increase in congenital anomalies, placental abruption, or postpartum hemorrhage with low-dose aspirin used as recommended.
  • Do not use aspirin if you have an aspirin/NSAID allergy, active bleeding, certain bleeding disorders, or active peptic ulcer disease; discuss individual risks with your clinician.
  • Avoid routine NSAIDs like ibuprofen after 20 weeks of pregnancy; if an NSAID is prescribed earlier, ask about timing with aspirin and whether alternatives are safer.
  • Plan aspirin use with your prenatal team, including how to start, how to manage missed doses, and whether to hold around a scheduled birth.

What is preeclampsia and why do some pregnancies benefit from prevention?

Preeclampsia is a pregnancy-related hypertensive disorder that can harm the parent and baby, and it affects about 1 in 25 U.S. pregnancies. Preventive strategies like low-dose aspirin are recommended for people with specific risk factors because they lower the chance of developing preeclampsia and related complications.

Preeclampsia typically occurs after 20 weeks and can involve high blood pressure plus signs of organ involvement such as protein in the urine, liver or kidney dysfunction, or neurologic symptoms. It increases risks of preterm birth, fetal growth restriction, placental complications, and maternal morbidity, so preventing or delaying onset improves outcomes.

Who should take low-dose aspirin during pregnancy according to current guidelines?

Major U.S. guidelines recommend low-dose aspirin for pregnant people with at least one high-risk factor for preeclampsia or with more than one moderate risk factor. High-risk and moderate-risk categories are defined by ACOG/SMFM and the U.S. Preventive Services Task Force to help clinicians identify who benefits.

  • High-risk factors (any one qualifies for aspirin): prior preeclampsia, multifetal gestation (twins or higher), chronic hypertension, pregestational type 1 or type 2 diabetes, kidney disease, or autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome.
  • Moderate risk factors (more than one qualifies for aspirin): first pregnancy (nulliparity), obesity (BMI ≥30), family history of preeclampsia (mother or sister), Black race as a proxy for the impact of structural racism, lower income, maternal age ≥35 years, personal history of low birth weight or small for gestational age infant, prior adverse pregnancy outcome, more than 10-year interpregnancy interval, or conception by in vitro fertilization.

Your clinician will use your history, current health, and social risk factors to decide if you meet criteria. If your risk changes during pregnancy, aspirin can still be started up to 28 weeks when indicated.

When should you start and stop low-dose aspirin, and what dose is recommended?

In the United States, the recommended dose is 81 mg of aspirin daily starting between 12 and 28 weeks of gestation, ideally before 16 weeks, and continuing until delivery. The UK’s NICE guideline recommends 75–150 mg daily from 12 weeks until birth for eligible patients.

  • Start: 12–28 weeks, with best evidence when started before 16 weeks.
  • Dose: 81 mg daily in the U.S. because that is the standard tablet strength and evidence-based dose.
  • Stop: Continue until delivery; your clinician may individualize plans around a scheduled birth or specific bleeding risks.
  • Timing of the daily dose: Take at the same time each day; if you have stomach sensitivity, taking with food can help.
GuidelineWho qualifiesDoseStart weekStop
ACOG/SMFM (U.S.)≥1 high-risk or >1 moderate risk factor81 mg daily12–28 (ideal <16)Until delivery
USPSTF (U.S.)≥1 high-risk or >1 moderate risk factor81 mg dailyAfter 12 weeksUntil delivery
NICE (UK)High risk or >1 moderate factor75–150 mg dailyFrom 12 weeksUntil birth

How effective is low-dose aspirin at reducing preeclampsia, preterm birth, and growth restriction?

Across randomized trials, low-dose aspirin reduces the risk of preeclampsia by about 15%, preterm birth by about 20%, and fetal growth restriction by about 18% in eligible patients. These benefits are most consistent when aspirin is started by 16 weeks and continued through delivery.

The USPSTF 2021 evidence review found relative risk reductions of approximately 0.85 for preeclampsia, 0.80 for preterm birth, and 0.82 for small-for-gestational-age outcomes with daily low-dose aspirin. These effects translate to meaningful reductions in complications at the population level when targeted to people with defined risk factors.

Is low-dose aspirin safe for you and your baby—and who should not take it?

When used as recommended, low-dose aspirin is considered safe in pregnancy and is not associated with increased risks of congenital anomalies, placental abruption, or postpartum hemorrhage. People with an aspirin or NSAID allergy, active bleeding, certain bleeding disorders, or active peptic ulcer disease should not take it.

  • Generally safe: Extensive trials and guideline reviews report no increase in fetal malformations or perinatal mortality with low-dose aspirin used for preeclampsia prevention.
  • Neuraxial anesthesia: Low-dose aspirin alone is not a contraindication to epidural or spinal anesthesia at delivery.
  • Absolute or relative contraindications: Aspirin/NSAID allergy or aspirin-exacerbated respiratory disease; active gastrointestinal bleeding or peptic ulcer disease; severe hepatic dysfunction; and conditions with active bleeding risk require specialist input.
  • NSAIDs in pregnancy: The FDA advises avoiding routine NSAIDs at 20 weeks or later; this advisory does not apply to guideline-directed low-dose aspirin for preeclampsia prevention, which remains recommended when indicated.

Does aspirin interact with other medications or supplements during pregnancy?

Aspirin can interact with other drugs that affect bleeding or platelet function, so always review your medication and supplement list with your clinician. Notable interactions include other NSAIDs, anticoagulants or antiplatelet agents, and some supplements that may increase bleeding risk.

  • Other NSAIDs (e.g., ibuprofen, naproxen): Routine use after 20 weeks should be avoided in pregnancy; ibuprofen taken near the same time can blunt aspirin’s antiplatelet effect, so ask your clinician about alternatives and spacing if an NSAID is prescribed earlier in pregnancy.
  • Anticoagulants/antiplatelets (e.g., heparins, warfarin, clopidogrel): Combined use can increase bleeding risk but may be appropriate in specific conditions like antiphospholipid syndrome under specialist care.
  • SSRIs/SNRIs and systemic corticosteroids: These can modestly increase bleeding or gastrointestinal irritation; monitor and discuss risk mitigation with your clinician.
  • Supplements: High-dose omega-3s and certain botanicals (e.g., ginkgo, high-dose garlic) may affect bleeding; share all over-the-counter products with your care team.

What side effects should you watch for, and when should you call your clinician?

Most people tolerate low-dose aspirin well, but mild stomach upset, heartburn, easy bruising, or nosebleeds can occur. Seek medical care urgently for signs of serious bleeding or allergic reaction.

  • Common, usually mild: dyspepsia or heartburn, nausea if taken on an empty stomach, small bruises, or occasional nosebleeds.
  • Call your clinician promptly: black or bloody stools, vomiting blood, unusual or heavy vaginal bleeding, severe or persistent abdominal pain, hives or wheezing, or any concern about decreased fetal movement.
  • Know preeclampsia warning signs regardless of aspirin use: severe or persistent headache, vision changes, right upper abdominal pain, sudden swelling of face/hands, or shortness of breath.

How do you discuss aspirin prophylaxis with your OB-GYN or midwife and build it into your prenatal plan?

Ask at your first prenatal visit whether your risk factors meet criteria for low-dose aspirin and when to start. If recommended, add aspirin to your prenatal medication list and confirm a plan for dosing, follow-up, and whether to hold it around a scheduled birth.

  1. Share your full history: prior pregnancies and outcomes, blood pressure readings, medical conditions, family history, and how you conceived (including IVF).
  2. Confirm eligibility: review high-risk and moderate-risk factors and decide together if you meet criteria.
  3. Set the plan: dose (81 mg), start date (by 12–16 weeks if possible), and how long to continue (until delivery unless individualized).
  4. Coordinate other meds: review any anticoagulants, pain relievers, or supplements to avoid interactions.
  5. Document it: include aspirin on your prenatal med list, pharmacy profile, and delivery plan, including guidance for epidural or cesarean if scheduled.
  6. Reassess at visits: if new risk factors arise or side effects occur, adjust the plan with your clinician.

Frequently Asked Questions

Should I start low-dose aspirin on my own if I think I’m at risk?

Do not start aspirin without discussing it with your clinician, because eligibility is based on specific risk factors and your overall health. Your OB-GYN or midwife can confirm the right dose and timing and check for any contraindications or interactions.

Do I need to stop aspirin before a planned cesarean or epidural?

Guidelines indicate low-dose aspirin alone is not a contraindication to neuraxial anesthesia, and many patients continue aspirin until delivery. Your clinician may individualize recommendations based on your bleeding risk and the details of a scheduled birth.

Is there a best time of day to take aspirin?

There is no universally required time of day; taking it at the same time daily supports adherence. If you have stomach sensitivity, taking aspirin with food can reduce mild gastrointestinal discomfort.

What if I miss a dose of aspirin?

If you miss a dose and remember within the same day, take it when you remember; if it is close to the next dose, skip the missed dose and resume your regular schedule. Do not double up doses to catch up.

Can low-dose aspirin prevent miscarriage?

Low-dose aspirin is not recommended to prevent miscarriage in the general population and is used specifically for preeclampsia prevention in eligible pregnancies. Certain conditions like antiphospholipid syndrome require specialized regimens that may include aspirin plus heparin under specialist care.

Sources

  1. ACOG — Low-Dose Aspirin Use During Pregnancy
  2. USPSTF — Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication
  3. NICE — Hypertension in pregnancy: diagnosis and management (NG133)
  4. CDC — High Blood Pressure During Pregnancy
  5. FDA — FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later
  6. FDA — Concomitant Use of Ibuprofen and Aspirin: Potential for Attenuation of the Anti-Platelet Effect of Aspirin (Drug Safety Communication)
  7. NIH Office of Dietary Supplements — Omega-3 Fatty Acids Fact Sheet for Health Professionals

The views, statements, and pricing expressed are deemed reliable as of the published date. Articles may not reflect current pricing, offerings, or recent innovations.